
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Center for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee; 2 Paul P. Carbone Comprehensive Cancer Center and 3 Department of Population Health Sciences, University of Wisconsin-Madison, Madison, Wisconsin; 4 Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire; 5 Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6 Core Genotyping Facility, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Gaithersburg, Maryland; and 7 H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Requests for reprints: Kathleen M. Egan, H. Lee Moffitt Cancer Center and Research Institute, Medical Research Center, 2nd Floor, 12902 Magnolia Drive, Tampa, FL 33612. Phone: 813-745-6149; Fax: 813-745-6525. E-mail: Kathleen.Egan{at}Moffitt.org
The availability of large amounts of genomic DNA (gDNA) is the limiting factor for many of the molecular biology assays in genetic epidemiologic studies. Whole-genome amplification using multiple displacement amplification is used to amplify a representative sample of gDNA from small amounts of gDNA to optimize gDNA yield. We collected oral rinse DNA samples through the mail from 3,377 women enrolled in a population-based U.S. breast cancer case-control study and did whole-genome amplification by multiple displacement amplification. Genotyping was done for 66 single nucleotide polymorphisms (SNP) in 18 candidate susceptibility genes using amplified DNA with genomic replicates included for quality control. The concordance rates (percentages of agreement) in 95 quality control replicates of gDNA and amplified DNA for 66 SNPs ranged from 88% to 100% (median, 97%). The average allelic error rate was 0.9%. However, in further analyses based on the full control series (n = 1,492), >60% of the SNPs failed tests for Hardy-Weinberg equilibrium (P < 0.05), with evidence of heterozygote loss in the great majority. Even eliminating the 9% of samples with lower quality or input DNA, tests for Hardy-Weinberg equilibrium indicated persistent allele bias in nearly a third of the SNPs. Whole-genome amplification may introduce substantial allele amplification bias in gDNA collected using a common protocol in population-based epidemiologic studies. (Cancer Epidemiol Biomarkers Prev 2007;16(8):1610–4)
This article has been cited by other articles:
![]() |
J. M. Cunningham, T. A. Sellers, J. M. Schildkraut, Z. S. Fredericksen, R. A. Vierkant, L. E. Kelemen, M. Gadre, C. M. Phelan, Y. Huang, J. G. Meyer, et al. Performance of Amplified DNA in an Illumina GoldenGate BeadArray Assay Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1781 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Beckett, S. J. Laughton, L. D. Pozza, G. B. McCowage, G. Marshall, R. J. Cohn, E. Milne, and L. J. Ashton Buccal Swabs and Treated Cards: Methodological Considerations for Molecular Epidemiologic Studies Examining Pediatric Populations Am. J. Epidemiol., May 15, 2008; 167(10): 1260 - 1267. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |